BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients
N/A
This study aims to determine if patients with higher BMI can tolerate highe...
Status
Unknown
Location
Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Start Date
2023-08-10
Trial ID
NCT06439069
Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.
N/A
This was a retrospective cohort study utilizing IQVIA open-source pharmacy ...
Status
Completed
Location
IQVIA
Start Date
2022-03-11
Trial ID
NCT05848206
An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan
N/A
This is an observational study in which data already collected from people ...